Ahmed Abdulgawad

Haematology Consultant in Cellular Therapies and Early Phase Trials

[Ahmed Abdulgawad @aamaaaeg]

A unique opportunity to advance your career with a world-renowned cancer center. Be part of a premier team dedicated to the research and clinical delivery of cutting-edge cell therapy innovations.

https://t.co/chzBu5Heoj

[Ahmed Abdulgawad @aamaaaeg]

https://t.co/GkB3Z3ISSq

[Ahmed Abdulgawad @aamaaaeg]

https://t.co/lmpbqt3ZTZ

Christie has been rated the 3rd best acute trust in the UK. The highest on the list for cancer care in the UK, a testimony for Christie’s unrivallled patient care.

[Ahmed Abdulgawad @aamaaaeg]

@Uber
I have my scheduled ride cancelled without prior notice and got charged for this.

Even worse, there is no easy way to report that.

This is unacceptable

[Ahmed Abdulgawad @aamaaaeg]

Bendamustine, should be avoided if possible ahead of Apharesis. #CART25 #theEBMT #EHA_Hematology #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

CD19 targeting through CART pathway? Probably a safe / effective strategy? More evidence is needed. #CART25 #theEBMT #EHA_Hematology #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

TCE in the CART pathway #CART25 #theEBMT #EHA_Hematology #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

Options for progression post CART? May be TCE? Another CAR? Or allograft?
#CART25 #theEBMT #EHA_Hematology #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

Other targets as CD22 for CD19 CAR exposed disease? #CART25 #theEBMT #EHA_Hematology #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

#CART25 #theEBMT #EHA_Hematology #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

CAR-HLH (or IEC-HS) is a rare fatal poorly understood complication of CART. Interferone gamma and JAK-STAT pathway may have a key role? Will Ruxolitinib be useful?

[Ahmed Abdulgawad @aamaaaeg]

Dual targeting is a promising concept. Will targeting BCMA (beside CD19) be effective in relapsed NHL post CD19 CAR? Watch the space!
#CART2025 #theEBMT #EHA_Hematology #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

Inflammatory state at baseline as a predictor of CV complications. #CART2025 #theEBMT #EHA_hematology #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

CV mortality contributes to the NRM in CART. Certainly less prominent than infection but worths a reminder during counselling patients. #CART2025 #theEBMT #EHA_Hematology #CART_is_he_future

[Ahmed Abdulgawad @aamaaaeg]

Possible mechanisms of CV toxicity with CART. May be off target off tumor is the most prominent?
#CART25 #theEBMT #EHA_hematology #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

Ways to overcome CART failure #CART2025 #The_EBMT #EHA_hematology #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

CART or allograft in rrCLL?
Many times allograft is not possible and even more times CART is not available!! Luckily, CART seams to work on CLL! #CART2025 #EHA_hematology #the_EBMT #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

Tremendous sucess for #CART in paediatric ALL. Early relapse post allo still comprises an area of unmet need. #CART2025 #theEBMT #EHA_HEMATOLOGY #CART_is_the_future

[Ahmed Abdulgawad @aamaaaeg]

Still a long way to go for #CART in myeloid malignancies. Modified stem cells appear to be a step in the right direction. #CART2025 #theEBMT #EHA_hematology #CART_is_the_future